| PENTIXAPHARM HLDG NA O.N. |
| Deutschland |
| Gesundheit |
| DE000A40AEG0 / A40AEG |
| PTP (Frankfurt) |
| FRA:PTP, ETR:PTP, PTP:GR |
| - |
| https://www.pentixapharm... |
|
Pentixapharm Holding AG is a clinical-stage biopharmaceutical company specializing in the development of radiopharmaceuticals. It focuses on CXCR4 ligand-based technologies for theranostic applications, combining diagnosis and therapy in hematologica..
>Volltext.. |
| 53.25 Mio. EUR |
| 48.06 Mio. EUR |
| - |
| - |
| - |
| - |
| - |
| 5.14 Mio. EUR |
| - |
| 1.75 |
| - |
| - |
| - |
| - |
| - |
| - |
| PENTIXAPHARM |
| 20.05.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|